Why is it that most of the
Bard senior management (Weiland, Ring, etc.) have sold
significant blocks of stock recently? I find this curious
since they all received significant grants of
restricted stock tied to the stock price coupled with the
fact that the stock price was bolstered by repurchases
of stock from the sale of cardiology until it hit
the strike price. Is no one looking out for the
stockholders, customers or employees?
The lifeblood of a
corporation is new products. My guideline is a product that
achieves $1,000,000 of first year sales in this industry
is a successful one. How many products has Bard
released in the last 2-3 years that meet this criteria?
Everything that Bard is touting seems to be an acquired
product, an old product in new clothes or a promise for
of you play with each other an another board? I
won't suggest another place to go.
It would be
nice to check this board for insight on Bard and not
be subject to senseless drivell. I think that I
speak for many in this request. But then again, I could
by: lesion_of_honor 1264 of 1332
correctly, SPNC is seeing a minor and temporary windfall due
to extremely ethical behavior on the part of BSX
management. This is in sharp contrast to Bard's behavior
during the Probe fiasco. I've already sold my shares and
bought some puts on SPNC, I suggest you do the same...
YOU GET A LIFE --- ANAL-SPAMMING LIAR!!!